Alzevita

by TOPIA MEDTECH LIMITED  · Based in India → — Advancing AI-Powered Brain MRI Analysis
Neurology Radiology

Contact vendor for pricing
Regulatory Status Disclosed

Overview

Alzevita is a cutting-edge, cloud-based AI-powered medical image processing software designed to assist neurologists, radiologists, and imaging labs in the analysis of 3D brain MRI scans. The tool automates hippocampal segmentation and volumetric reporting, providing consistent, quantifiable results from brain MRI scans. This supports objective reporting and helps streamline clinical workflows, enhancing speed, reproducibility, and confidence in neuroimaging.

Alzevita leverages state-of-the-art deep learning techniques, including UNet++ Architecture, ResNet Backbone, and Split Attention Mechanism, to deliver precise segmentation and volumetric analysis of the hippocampus. This innovation is designed to significantly enhance early diagnosis and monitoring of neurodegenerative conditions, such as Alzheimer’s disease, by identifying and quantifying changes in hippocampal structure. It supports industry-standard imaging formats like DICOM and NIFTI, making it interoperable and easy to integrate into existing radiology infrastructures.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-Based Hippocampal Segmentation
  • Quantitative Volumetric Analysis of Brain Structures
  • High Reproducibility and Standardization of Outputs
  • Supports Industry-Standard Imaging Formats (DICOM, NIFTI)
  • Cloud-Based Deployment
  • Assists Neurologists and Radiologists in Diagnosis
  • Supports Objective Reporting
  • Streamlines Clinical Workflows
  • Enhances Diagnostic Confidence
  • Utilizes Advanced Deep Learning Techniques (UNet++, ResNet, Split Attention)

Use Cases

  • Early diagnosis and monitoring of Alzheimer's Disease
  • Assessment of neurodegenerative conditions
  • Automated brain MRI analysis for radiologists and imaging labs
  • Evaluating structural brain changes over time
  • Integration into clinical and research settings
  • Replacing manual hippocampal segmentation workflows

What Physicians Need to Know

Brain MRI Analysis
Alzevita is an AI-powered, cloud-based software designed for the automated segmentation and volumetric quantification of the hippocampus from 3D brain MRI scans. It supports industry-standard imaging formats such as DICOM and NIfTI.
Neurodegenerative Disease Screening
The tool is intended to assist in the diagnosis and monitoring of neurodegenerative conditions, particularly Alzheimer's disease, by providing quantitative measurements of hippocampal volume. It aids healthcare professionals in evaluating structural brain changes and detecting early signs of neurodegeneration.
Mobile Accessibility & Reporting
As a cloud-based platform, Alzevita offers access from any device, eliminating the need for costly hardware installations. It generates standardized PDF reports with volumetric measurements, designed for neurologists, radiologists, and memory-care specialists.
Physician Tip

Alzevita streamlines the analysis of brain MRI scans by automating hippocampal segmentation and volumetric quantification, offering fast, reproducible, and standardized results. This can significantly reduce manual effort, improve workflow efficiency, and provide objective data for supporting the interpretation, reporting, and longitudinal comparison of structural brain changes in neurodegenerative conditions. Leverage the standardized volumetric reports to enhance communication with patients and referring clinicians, and to track disease progression more precisely over time.

Alzevita supports industry-standard imaging formats including DICOM and NIfTI, facilitating seamless integration into existing radiology infrastructure and DICOM workflows. The platform is designed to generate structured reports, which can be incorporated into daily clinical practice and research settings.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Contact vendor for pricing
DeploymentCloud
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Alzevita (K252670) is a Class II medical device, product code QIH (Automated Radiological Image Processing Software), regulated under 21 CFR 892.2050 (Medical Image Management And Processing System). It is intended to assist neurologists and radiologists with expertise in the analysis of 3D brain MRI scans by performing automated segmentation and volumetric quantification of the hippocampus.

Integrations
EHR Not specified
Specialties Neurology, Radiology

What the Web Says

Alzevita is an AI-powered, cloud-based medical image processing software designed to simplify and standardize brain MRI segmentation and volumetric analysis, primarily focusing on the hippocampus. It aims to assist neurologists, radiologists, and researchers by providing fast, consistent, and reproducible brain volume data, thereby streamlining workflows and enhancing decision support. The software has received US FDA 510(k) clearance and is licensed under CDSCO (India) Medical Device Rules.

Overall: Positive

Strengths

  • Automated hippocampal segmentation, reducing manual effort and variability.
  • Generates fast, consistent, and reproducible brain volume data.
  • Provides standardized PDF reports for efficient analysis.
  • Cloud-based processing, offering scalability and accessibility without high-end hardware.
  • Validated for accuracy against expert manual annotations with high geometric agreement.
  • Compatible with standard DICOM and NIfTI brain MRI files.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • Alzevita is a clinical decision-support tool and does not replace qualified healthcare professionals for final interpretation and diagnosis.

Based on reviews from: Alzevita u2013 AI MRI Segmentation Software, Alzevita Brochure, Schedule a Meeting | AI Hippocampal MRI Volumetric - Alzevita

Last updated: 2026-07-19

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Alzevita

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Topia MedTech
A Proud Milestone: Alzevita Receives FDA 510(k) Clearance
Alzevita, an AI-powered medical image processing software, received FDA 510(k) clearance (K252670) on January 6, 2026, marking a significant regulatory achievement for the company.
2026-01
Alzevita (Topia MedTech)
Alzevita: AI powered Brain Segmentation & MRI Volumetry
Alzevita is a cloud-based, AI-powered medical image processing software designed to assist neurologists, radiologists, and researchers in analyzing 3D brain MRI scans by automating hippocampal segmentation and volumetric quantification.
2025-12
Topia MedTech
Alzevita u2013 AI MRI Segmentation & Volumetry Tool
Alzevita is a cutting-edge imaging tool that automates hippocampal segmentation and volumetric brain analysis from MRI scans, providing consistent and quantifiable results to support objective reporting and streamline clinical workflows.
unknown
unknown
AI in Medical Devices Market Size & Share, Growth Analysis 2035
Alzevita is listed as an FDA-cleared AI in medical devices, with its clearance date noted as December 19, 2025, within a market analysis report on the growth of AI in medical devices.
2026-04
Alzevita Blog
Alzevita Blog - AI, Imaging & Digital Health Updates
The Alzevita Blog provides updates on AI, imaging, and digital health, featuring articles on topics such as AI's role in brain MRI analysis and the challenges of Alzheimer's disease.
2026-07
Alzevita (Topia MedTech)
Alzevita Brochure
Alzevita is introduced as a groundbreaking AI tool to support the diagnosis of neurological conditions like Alzheimer's disease by automating hippocampal segmentation and volumetric analysis from MRI scans.
unknown
Alzevita (Topia MedTech)
Alzevita Events | Explore AI Breakthroughs in Alzheimer's
Alzevita has participated in several key conferences, including IRIA Annual Conference 2026, RSNA 2025, Neuro Care 2026 International Conference, and Alzheimer's Society Conference 2025, showcasing its AI-driven approach to hippocampal analysis.
2026-03
Topia MedTech
Topia MedTech - The Future of Healthcare Innovation
Topia MedTech highlights Alzevita as one of its flagship products, an AI-based MRI segmentation and volumetry tool that supports radiologists with fast, consistent brain imaging analysis, enhancing clinical efficiency.
unknown

Videos

Product demos, reviews, and walkthroughs for Alzevita.

Loading videos...

View all on YouTube

Frequently Asked Questions

Alzevita is a cloud-based, AI-powered medical image processing software designed for seamless integration into existing radiology infrastructure, supporting industry-standard imaging formats like DICOM and NIfTI. It automates hippocampal segmentation and volumetric quantification from 3D brain MRI scans, providing structured reports that can be easily incorporated into daily practice.
Alzevita is FDA Cleared (510(k)-K252670) and CDSCO Approved (MFG/MD/2026/000125) as a medical device for its intended use in brain MRI analysis. As a cloud-based solution, it is built with compliance first, adhering to strict data privacy protocols to protect patient information.
Alzevita provides automated, reproducible segmentation and volumetric quantification of the hippocampus, a brain structure involved in memory and commonly affected by neurodegenerative conditions. This assists neurologists and radiologists in evaluating structural brain changes, standardizing reporting, and enhancing diagnostic confidence and follow-up comparisons.
Alzevita is designed to replace manual hippocampal segmentation workflows with a fast, reproducible, and standardized AI-powered process, minimizing manual effort and variability. It offers consistent volumetric outputs, which can be superior to traditional, often subjective, manual methods and streamlines workflows more efficiently.
While specific pricing details are not publicly available, Alzevita typically operates on a subscription-based model. Its value proposition includes improved workflow efficiency, reduced manual effort, and standardized, reproducible results, which can lead to cost savings and enhanced diagnostic throughput for practices.
Alzevita is a clinical decision support tool, meaning human clinical judgment remains paramount; it is not intended to replace professional expertise. While highly accurate, like all AI, its performance may be influenced by the diversity of its training data, and physicians must critically review all AI-generated insights.
As a cloud-based medical device, Alzevita utilizes secure infrastructure and supports industry-standard imaging formats like DICOM and NIfTI. It is built with compliance in mind, implying robust data security measures and protocols to protect sensitive patient information throughout its processing and storage.

Related Tools

Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.
Brainomix 360 Hyperdensity
Brainomix Limited
Neurology AI
Brainomix 360 Hyperdensity is an AI-powered neuroimaging software tool that detects and quantifies brain hyperdensities on CT scans, forming a crucial part of the Brainomix 360 Stroke platform for rapid and accurate stroke assessment.
SOMNUM
HoneyNaps
Clinical Decision Support & Reference
SOMNUM is an AI-enabled medical software tool by Honeynaps Co., Ltd. that provides comprehensive sleep analysis to aid in the diagnosis and management of sleep disorders.
DETECT-ME/CFS project
DETECT-ME/CFS project (ME/CFS Research Foundation)
Clinical Decision Support & Reference
The DETECT-ME/CFS project is developing an AI-supported clinical decision support system to improve the rapid and reliable diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

See all Neurology AI tools →

Suggest an Edit → | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.